The US weight loss market was valued at $159.69 billion in 2021 and is expected to reach $305.30 billion by 2030, with a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030. The weight loss industry includes products and services such as: Weight loss supplements, Meal replacement programs, Fitness equipment, Weight loss programs, and Surgical procedures like liposuction and gastric bypass surgery.
According to Goldman Sachs, the anti-obesity drug market could grow to $100 billion by 2030, with Eli Lilly & Co. and Novo Nordisk A/S leading the pack. These drugs stimulate key receptors in the gastrointestinal tract and brain to promote insulin synthesis, decrease feelings of hunger, and achieve weight loss up to the mid-20%